154 related articles for article (PubMed ID: 14636881)
21. Hyperglycosylated hCG is a marker of early human trophoblast invasion.
Guibourdenche J; Handschuh K; Tsatsaris V; Gerbaud P; Leguy MC; Muller F; Brion DE; Fournier T
J Clin Endocrinol Metab; 2010 Oct; 95(10):E240-4. PubMed ID: 20660042
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
23. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
[TBL] [Abstract][Full Text] [Related]
24. Hyperglycosylated-hCG: Its Role in Trophoblast Invasion and Intrauterine Growth Restriction.
Herghelegiu CG; Veduta A; Stefan MF; Magda SL; Ionascu I; Radoi VE; Oprescu DN; Calin AM
Cells; 2023 Jun; 12(12):. PubMed ID: 37371117
[TBL] [Abstract][Full Text] [Related]
25. Hyperglycosylated HCG expression in pregnancy: cellular origin and clinical applications.
Kovalevskaya G; Kakuma T; Schlatterer J; O'Connor JF
Mol Cell Endocrinol; 2007 Jan; 260-262():237-43. PubMed ID: 17092638
[TBL] [Abstract][Full Text] [Related]
26. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
27. Human chorionic gonadotropin: Different glycoforms and biological activity depending on its source of production.
Fournier T
Ann Endocrinol (Paris); 2016 Jun; 77(2):75-81. PubMed ID: 27177499
[TBL] [Abstract][Full Text] [Related]
28. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
Cole LA; Muller CY
Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
[TBL] [Abstract][Full Text] [Related]
29. Review: hCGs: different sources of production, different glycoforms and functions.
Fournier T; Guibourdenche J; Evain-Brion D
Placenta; 2015 Apr; 36 Suppl 1():S60-5. PubMed ID: 25707740
[TBL] [Abstract][Full Text] [Related]
30. Verification of early pregnancy tests in a multicenter trial.
Jovanovic L; Singh M; Saxena BB; Mills JL; Tulchinsky D; Holmes LB; Simpson JL; Metzger BE; Labarbera A; Aarons J
Proc Soc Exp Biol Med; 1987 Feb; 184(2):201-5. PubMed ID: 3809174
[TBL] [Abstract][Full Text] [Related]
31. Hyperglycosylated hCG, a review.
Cole LA
Placenta; 2010 Aug; 31(8):653-64. PubMed ID: 20619452
[TBL] [Abstract][Full Text] [Related]
32. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG.
Cole LA; Dai D; Butler SA; Leslie KK; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):145-50. PubMed ID: 16631920
[TBL] [Abstract][Full Text] [Related]
33. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening.
Cole LA; Omrani A; Cermik D; Singh RO; Mahoney MJ
Prenat Diagn; 1998 Sep; 18(9):926-33. PubMed ID: 9793975
[TBL] [Abstract][Full Text] [Related]
34. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma.
Handschuh K; Guibourdenche J; Tsatsaris V; Guesnon M; Laurendeau I; Evain-Brion D; Fournier T
Endocrinology; 2007 Oct; 148(10):5011-9. PubMed ID: 17628005
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycosylated hCG.
Cole LA
Placenta; 2007 Oct; 28(10):977-86. PubMed ID: 17346790
[TBL] [Abstract][Full Text] [Related]
36. Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-β receptor activation.
Berndt S; Blacher S; Munaut C; Detilleux J; Perrier d'Hauterive S; Huhtaniemi I; Evain-Brion D; Noël A; Fournier T; Foidart JM
FASEB J; 2013 Apr; 27(4):1309-21. PubMed ID: 23233533
[TBL] [Abstract][Full Text] [Related]
37. Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE; Pandian R
Clin Chem; 2004 Oct; 50(10):1804-8. PubMed ID: 15319323
[TBL] [Abstract][Full Text] [Related]
38. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis.
Cole LA; Khanlian SA; Riley JM; Butler SA
J Reprod Med; 2006 Nov; 51(11):919-29. PubMed ID: 17165440
[TBL] [Abstract][Full Text] [Related]
39. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
40. Specificity and detection limit of ten pregnancy tests.
Alfthan H; Björses UM; Tiitinen A; Stenman UH
Scand J Clin Lab Invest Suppl; 1993; 216():105-13. PubMed ID: 7690982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
